Live from the NIH registry
Studies recruiting near Lafayette right now
Top 25 of 62 recruiting studies, sorted by proximity — each links to its official registry page
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Sparrow Pharmaceuticals
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: GlaxoSmithKline
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: Akero Therapeutics, Inc
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Abbeville General Hospital — Abbeville, Louisiana (17.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Velocity Clinical Research — Lafayette, Louisiana (1.3 mi)
· Sponsor: Eli Lilly and Company
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative Colitis, Obesity or Overweight
Phase 3
Interventional 350 participants sought
Care Access - New Iberia — New Iberia, Louisiana (19.1 mi)
· Sponsor: Eli Lilly and Company
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Moderate-to-Severe Atopic Dermatitis
Phase 3
Interventional 510 participants sought
Nektar Investigative Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: Nektar Therapeutics
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: Alnylam Pharmaceuticals
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: DalCor Pharmaceuticals
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Velocity Clinical Research, Lafayette — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pfizer
Pelacarsen Roll-over Extension Program
Atherosclerotic Cardiovascular Disease
Phase 3
Interventional 599 participants sought
CV Ins of the South — Opelousas, Louisiana (22.7 mi)
· Sponsor: Novartis Pharmaceuticals
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Pacific Edge Limited
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 980 participants sought
Care Access - New Iberia-Site Number: 8400031 — New Iberia, Louisiana (19.1 mi)
· Sponsor: Sanofi
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
Benign Prostatic Hyperplasia
N/A
Interventional 215 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Rivermark Medical
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Crohn's Disease, Obesity or Overweight
Phase 3
Interventional 290 participants sought
Care Access - New Iberia — New Iberia, Louisiana (19.1 mi)
· Sponsor: Eli Lilly and Company
PSMA PET Combined With MRI for the Detection of PCa
PCA, Prostate Cancer
Phase 3
Interventional 338 participants sought
Southern Urology — Lafayette, Louisiana (1.3 mi)
· Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms
Phase 2
Interventional 308 participants sought
Southern Urology, LLC ( Site 0145) — Lafayette, Louisiana (1.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ulcerative Colitis, Crohn's Disease
Phase 4
Interventional 200 participants sought
Combined Gastro LLC — Lafayette, Louisiana (1.3 mi)
· Sponsor: Takeda
The THOR IDE Study
Peripheral Artery Disease, Peripheral Artery Stenosis
N/A
Interventional 155 participants sought
Cardiovascular Institute of the South — Lafayette, Louisiana (1.3 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 644 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC)
Phase 2
Interventional 140 participants sought
Mirador Therapeutics Selected Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: Mirador Therapeutics, Inc.
Phase 2 Clinical Trial of CartiLife® in the United States
Articular Cartilage Defect, Articular Cartilage Degeneration
Phase 2
Interventional 25 participants sought
Lafayette General Health — Lafayette, Louisiana (1.3 mi)
· Sponsor: Biosolution Co., Ltd.
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 530 participants sought
Gastroenterology Clinic of Acadiana — Lafayette, Louisiana (1.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Lafayette, Louisiana (1.3 mi)
· Sponsor: 89bio, Inc.